Among patients who transformed into secondary myelofibrosis, 4 were not receiving treatment, 9 received anagrelide, 13 received hydroxyurea and 7 received alpha-pegylated interferon at the time of CD34-positive cell quantification (Fig. 1A, Supplemental Figure S2). Here, CD34 is linked to myelofibrosis.